Natural History of Atypical Morquio A Disease: a 5-years Prospective Study in a Series of 9 Adult Patients Followed in a Single Expert Center
Phase of Trial: Phase IV
Latest Information Update: 14 Feb 2019
At a glance
- Drugs Elosulfase alfa (Primary)
- Indications Mucopolysaccharidosis IV
- Focus Therapeutic Use
- 05 Feb 2019 Planned End Date changed from 1 Jul 2022 to 1 Jul 2023.
- 05 Feb 2019 Planned primary completion date changed from 1 Jul 2019 to 1 Feb 2020.
- 05 Feb 2019 Status changed from not yet recruiting to recruiting.